These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 21243007)

  • 21. Prostate cancer screening: a survey of attitudes and practices among Finnish physicians in 1999 and 2007.
    Pogodin-Hannolainen D; Juusela H; Tammela TL; Ruutu M; Aro J; Määttänen L; Auvinen A
    J Med Screen; 2011; 18(1):46-9. PubMed ID: 21536817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PSA screening in New Zealand: total population results and general practitioners' current attitudes and practices.
    van Rij S; Dowell T; Nacey J
    N Z Med J; 2013 Aug; 126(1381):27-36. PubMed ID: 24150262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minority issues in prostate disease.
    French DB; Jones LA
    Med Clin North Am; 2005 Jul; 89(4):805-16. PubMed ID: 15925651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioral associations between prostate and colon cancer screening.
    Carlos RC; Underwood W; Fendrick AM; Bernstein SJ
    J Am Coll Surg; 2005 Feb; 200(2):216-23. PubMed ID: 15664097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer screening trends of New York State men at least 50 years of age, 1994 to 1997.
    McDavid K; Melnik TA; Derderian H
    Prev Med; 2000 Sep; 31(3):195-202. PubMed ID: 10964632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations of demographic and health-related characteristics with prostate cancer screening in Washington State.
    Close DR; Kristal AR; Li S; Patterson RE; White E
    Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):627-30. PubMed ID: 9681532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate cancer detection by using digital rectal examination: contemporary practice patterns in the United States.
    Tourville EA; Nguyen MM
    Clin Genitourin Cancer; 2013 Sep; 11(3):263-9. PubMed ID: 23647941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Educating men about prostate cancer screening. A randomized trial of a mailed pamphlet.
    Wilt TJ; Paul J; Murdoch M; Nelson D; Nugent S; Rubins HB
    Eff Clin Pract; 2001; 4(3):112-20. PubMed ID: 11434074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health information styles among participants in a prostate cancer screening informed decision-making intervention.
    Williams-Piehota PA; McCormack LA; Treiman K; Bann CM
    Health Educ Res; 2008 Jun; 23(3):440-53. PubMed ID: 18385197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PSA screening: determinants of primary-care physician practice patterns.
    Tasian GE; Cooperberg MR; Potter MB; Cowan JE; Greene KL; Carroll PR; Chan JM
    Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):189-94. PubMed ID: 22343837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of physician recommendation on prostate-specific antigen screening.
    Pucheril D; Dalela D; Sammon J; Sood A; Sun M; Trinh QD; Menon M; Abdollah F
    Urol Oncol; 2015 Oct; 33(10):424.e1-7. PubMed ID: 26206103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decision making in prostate-specific antigen screening National Health Interview Survey, 2000.
    Han PK; Coates RJ; Uhler RJ; Breen N
    Am J Prev Med; 2006 May; 30(5):394-404. PubMed ID: 16627127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
    Jønler M; Eddy B; Poulsen J
    Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoting prostate-specific antigen informed decision-making. Evaluating two community-level interventions.
    Driscoll DL; Rupert DJ; Golin CE; McCormack LA; Sheridan SL; Welch BM; Poehlman JA
    Am J Prev Med; 2008 Aug; 35(2):87-94. PubMed ID: 18617077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening tests.
    Haggerty J; Tudiver F; Brown JB; Herbert C; Ciampi A; Guibert R
    Can Fam Physician; 2005 Dec; 51(12):1658-9. PubMed ID: 16926946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unwanted control: how patients in the primary care setting decide about screening for prostate cancer.
    Woolf SH; Krist AH; Johnson RE; Stenborg PS
    Patient Educ Couns; 2005 Jan; 56(1):116-24. PubMed ID: 15590232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Difference in willingness-to-pay for prostate cancer screening between ill-informed and well-informed men: a contingent valuation survey.
    Yasunaga H; Sugihara T; Imamura T
    Urology; 2011 Jun; 77(6):1325-9. PubMed ID: 21507471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dissemination of evidence-based information about PSA test and prostatic cancer to physicians].
    Norderhaug IN; Wisløff T; Fosså S; Sandberg S; Malde K; Forland F; Førde OH
    Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2893-5. PubMed ID: 15550959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer prevention trials and primary care physicians: factors associated with recommending trial enrollment.
    Battaglia TA; Ash A; Prout MN; Freund KM
    Cancer Detect Prev; 2006; 30(1):34-7. PubMed ID: 16476525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demographics and health-related factors of men receiving prostate-specific antigen screening in Utah.
    Merrill RM
    Prev Med; 2001 Dec; 33(6):646-52. PubMed ID: 11716662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.